Sherbrooke Park Advisers »

Fulcrum Therapeutics shares owned by Sherbrooke Park Advisers

Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by Sherbrooke Park Advisers from 13F filings

Historical chart of Sherbrooke Park Advisers investment in Fulcrum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fulcrum Therapeutics held by Sherbrooke Park Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulcrum Therapeutics by Sherbrooke Park Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $79k 12k 6.75

More positions owned by Sherbrooke Park Advisers

Johnson & Johnson (JNJ)
Apple (AAPL)
Lennar Corp Cl A (LEN)
Ssr Mining (SSRM)
Smartsheet Com Cl A (SMAR)
Dow (DOW)
Gxo Logistics Incorporated Common Stock (GXO)
Royal Gold (RGLD)
Philip Morris International (PM)
Archer Daniels Midland Company (ADM)
Kraft Heinz (KHC)
Masco Corporation (MAS)
Reynolds Consumer Prods (REYN)
Etsy (ETSY)
Microsoft Corporation (MSFT)

View all positions for Sherbrooke Park Advisers

Top funds holding Fulcrum Therapeutics

RA Capital Management
FMR
Cowen And Company
Suvretta Capital Management
Vanguard Group
Trv Gp Iv
Caption Management
BlackRock
Citadel Advisors
Dimensional Fund Advisors
Morgan Stanley
Leucadia National Corporation
MPM Oncology Impact Management
Adage Capital Partners GP
Logos Global Management

View all funds holding Fulcrum Therapeutics